12,013 Shares in Stryker Co. (SYK) Acquired by Dupont Capital Management Corp

Dupont Capital Management Corp bought a new position in shares of Stryker Co. (NYSE:SYK) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 12,013 shares of the medical technology company’s stock, valued at approximately $1,883,000.

Several other large investors also recently bought and sold shares of SYK. Northwest Wealth Management LLC raised its position in shares of Stryker by 103.6% in the fourth quarter. Northwest Wealth Management LLC now owns 169 shares of the medical technology company’s stock worth $26,000 after buying an additional 86 shares in the last quarter. Horan Securities Inc. purchased a new stake in shares of Stryker in the fourth quarter worth $30,000. Moody National Bank Trust Division purchased a new stake in shares of Stryker in the fourth quarter worth $32,000. Exane Derivatives purchased a new stake in shares of Stryker in the fourth quarter worth $39,000. Finally, Parkside Financial Bank & Trust raised its position in shares of Stryker by 111.5% in the fourth quarter. Parkside Financial Bank & Trust now owns 406 shares of the medical technology company’s stock worth $64,000 after buying an additional 214 shares in the last quarter. Hedge funds and other institutional investors own 73.38% of the company’s stock.

In other news, VP Michael Damon Hutchinson sold 15,995 shares of the firm’s stock in a transaction dated Friday, February 8th. The stock was sold at an average price of $180.49, for a total transaction of $2,886,937.55. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP M Kathryn Fink sold 180 shares of the firm’s stock in a transaction dated Monday, February 4th. The shares were sold at an average price of $176.77, for a total value of $31,818.60. The disclosure for this sale can be found here. In the last three months, insiders sold 43,259 shares of company stock worth $7,515,747. 7.30% of the stock is owned by insiders.

A number of brokerages recently issued reports on SYK. Zacks Investment Research upgraded Stryker from a “hold” rating to a “buy” rating and set a $199.00 price objective on the stock in a research report on Monday, February 4th. Cantor Fitzgerald reiterated a “neutral” rating on shares of Stryker in a research report on Friday, January 18th. Oppenheimer set a $170.00 price objective on Stryker and gave the stock a “hold” rating in a research report on Friday, November 9th. SunTrust Banks increased their price objective on Stryker to $205.00 and gave the stock a “positive” rating in a research report on Monday, February 4th. Finally, Canaccord Genuity increased their price objective on Stryker from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, January 30th. Seven analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Stryker currently has an average rating of “Buy” and an average price target of $185.37.

SYK opened at $182.66 on Friday. The firm has a market capitalization of $67.63 billion, a P/E ratio of 24.73, a PEG ratio of 2.22 and a beta of 0.86. The company has a current ratio of 2.02, a quick ratio of 1.21 and a debt-to-equity ratio of 0.72. Stryker Co. has a 52 week low of $144.75 and a 52 week high of $182.69.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 29th. The medical technology company reported $2.18 EPS for the quarter, beating the Zacks’ consensus estimate of $2.15 by $0.03. The business had revenue of $3.80 billion for the quarter, compared to analysts’ expectations of $3.73 billion. Stryker had a return on equity of 27.60% and a net margin of 26.12%. As a group, sell-side analysts anticipate that Stryker Co. will post 8.12 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 30th. Investors of record on Friday, March 29th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $2.08 dividend on an annualized basis and a yield of 1.14%. Stryker’s dividend payout ratio is presently 28.45%.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2019/02/09/12013-shares-in-stryker-co-syk-acquired-by-dupont-capital-management-corp.html.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Further Reading: What is the float in trading stocks?

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit